BackSpectrum Pharmaceuticals Overview

Spectrum Pharmaceuticals Research & Development

Research & Development expenses for SPPI.

Quarterly R&D Expenses

$5.42M
↑ 29.36% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$43.43M
↓ 39.77% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin